ANDREW HULL - 11 Jan 2025 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull
Issuer symbol
INM
Transactions as of
11 Jan 2025
Transactions value $
$0
Form type
4
Filing time
03 Feb 2025, 08:49:05 UTC
Previous filing
23 Dec 2024
Next filing
19 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -2 -0.2% $0 975 11 Jan 2025 Common shares 2 $2,860.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$4,125.00 using an exchange rate of C$1.4422 = $US1.00